Alira Health and AseBio Announce Market Access Mentoring Program for 2024

Following the success of the 2023 program, Alira Health, a global healthcare advisory and technology company, and AseBio, the Spanish Bioindustry Association, are pleased to announce the 2024 edition of their market access mentoring program for AseBio members.

The 2024 edition is the second edition of the Market Access Mentoring Program by Alira Health and AseBio. The 2023 program, with the goal to promote access to innovation, was highly successful, with 100% of the participating biotech startups stating that they would recommend the program to others.

Alira Health pairs its experienced market access consultants with small and medium-sized enterprises (SMEs) to improve their value proposition, help them navigate the ecosystem, and properly define their market access needs.

News
Published on:
January 24, 2024
We are delighted by the success of the AseBio mentoring program in 2023 and look forward to working with a new group of entrepreneurs in 2024. It’s all part of our commitment to boost biotech companies and strengthen innovation in Spain.
Chus Castillo Partner Consulting Iberia, Alira Health

The 2024 edition format includes a 40-hour service package for three companies that includes an initial meeting, background analysis, tailored orientation session for market access and pricing, and gap analysis.

The 2024 program application will open on January 25th and close on February 21st. All AseBio biotech SMEs are eligible to apply by completing the online application form. Candidates’ presentations will be held in March.

“We received very positive feedback from the first edition of the program. The participating companies highly valued the opportunity to work hand in hand with the Alira Health team, whose experience allowed them to identify where and how they can strengthen their products,” says Ion Arocena, General Director of AseBio.

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.